CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating Activities
Net earnings	$ 176,279	$ 105,705
Loss on assets held for sale	0	(46,946)
Adjustments to reconcile net earnings to cash from operating activities:
Depreciation and amortization	68,752	67,738
Share-based compensation expense	3,252	8,182
Other, net	(17,358)	2,363
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):
Accounts receivable, net	(25,313)	(42,252)
Inventories	(61,936)	(73,041)
Prepaid expenses and other assets	(8,654)	(14,921)
Accounts payable	(25,245)	(22,638)
Accrued compensation and employee benefits	(67,247)	(55,559)
Accrued expenses and other liabilities	25,321	(16,107)
Accrued and deferred taxes, net	14,563	18,108
Net cash provided by operating activities	75,863	24,524
Investing Activities
Additions to property, plant and equipment	(40,172)	(37,122)
Acquisitions, net of cash acquired	208,421	175,083
Proceeds from sale of property, plant, and equipment	1,232	170
Proceeds from sale of businesses	16,850	2,245
Other	0	(7,900)
Net cash (used in) provided by investing activities	(230,511)	(217,690)
Financing Activities
Repurchase of common stock, including prepayment under an accelerated share repurchase program	(52,916)	0
Change in commercial paper and notes payable	415,300	125,893
Dividends paid to stockholders	(70,899)	(69,809)
Payments to settle employee tax obligations on exercise of share-based awards	(10,019)	(19,608)
Other	(512)	(409)
Net cash used in by financing activities	280,954	36,067
Effect of Exchange Rate on Cash and Cash Equivalents	(14,652)	3,892
Net (decrease) increase in cash and cash equivalents	111,654	(153,207)
Cash and cash equivalents at beginning of period	397,253	396,221
Cash and cash equivalents at end of period	$ 508,907	$ 243,014